Group One Trading
NVIV

Group One Trading’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Group One Trading’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Hold
0
– -$31K – 5814
2018
Q1 		– Hold
0
– – – 3905
2017
Q3 		– Hold
0
– -$10K – 5454
2017
Q2 		– Hold
0
– – – 4232
2017
Q1 		– Hold
0
– – – 3662
2016
Q4 		– Hold
0
– – – 3464
2016
Q3 		– Sell
-7
Closed -$873K – 3422
2016
Q2 		$776K Hold
7
– – 0.01% 1412
2016
Q1 		$969K Buy
+7
New +$751K 0.01% 1198
2015
Q4 		– Hold
0
– – – 3792
2015
Q3 		– Hold
0
– – – 3885
2015
Q2 		– Hold
0
– – – 3252

Other funds holding NVIV

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's NVIV Position: Q1 2018 in Review

Group One Trading held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q1 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5660.

Group One Trading first reported a position in NVIV in Q4 2015 and has held it in 6 quarters since. The position peaked at $445K in Q4 2015. 25 funds tracked by Wall St. Rank hold NVIV as of Q1 2018.

  • Group One Trading held 0 shares of InVivo Therapeutics Holdings Corp worth $0 as of Q1 2018.
  • Group One Trading left its InVivo Therapeutics Holdings Corp share count unchanged in Q1 2018.
  • InVivo Therapeutics Holdings Corp made up ﹤0.01% of Group One Trading's portfolio in Q1 2018, its #5660 holding.
  • Group One Trading first reported a position in InVivo Therapeutics Holdings Corp in Q4 2015 and has held it in 6 quarters since.
  • Group One Trading's InVivo Therapeutics Holdings Corp position peaked at $445K in Q4 2015.
  • 25 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q1 2018.

Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.